According to the results, compared with those before treatment, regarding the SPP indicators, SAS, SDS, and VAS were significantly decreased, and PF, RP, BP, GH, VT, SF, RE, and MH of RA patients were increased after treatment; clinical indicators (FBG, DD, ESR, and Hs-CRP) were remarkably decreased (Table 2). This evidence concerns the gene ESR1 and rheumatoid arthritis.